Los puntos clave no están disponibles para este artículo en este momento.
Critical issues in determining therapeutic strategies for patients with myelodysplastic syndromes (MDSs), who usually die of bone marrow failure with or without conversion to acute myeloid leukemia (AML), include host factors in these mainly older patients, disease heterogeneity, lack of
Richard M. Stone (Wed,) studied this question.